30 closest matches · ranked by relevance
Coronary Artery Disease · Chest Pain
Primary: Number of Excess Double-strand DNA Break Foci Per Cell in Peripheral Blood Samples Post-imaging — 0.183; 0.159 gamma-H2AX foci in blood lymphocytes — p=<0.05
Radiation Exposure to Operator
Primary: Operator Radiation Exposure — .65; .56 mSv
Node Positive Breast Cancer
Primary: Cardiac MRI Parameters — 0; 0; 0; 0 number of patients
Occupational Radiation Exposure
Primary: Effective Radiation Dose — 0.0307; 0.0192 mSv
RAD
Primary: Radiation Readings — 122.8; 158.8; 236.9 mREM
Cardiac Catheterization · Radiation Exposure
Primary: Radiation Dose to Primary Operator (RaySafe), Cardiac Catheterization — 18; 39 microsievert
Occupational Exposure to Radiation
Primary: Radiation Attenuation in Percentage (%) — 12; 91.5; 97.1 Percentage
Arteriovenous Malformations · Aneurysm · Stenosis
Primary: Image Quality. For Each Included Participant 2 Images (1 AlluraXper; 1 AlluraClarity) Were Evaluated. — 9.4; 11.9; 13.1; 14.1 Scores on a scale
Cancer
Primary: Value of Mean Volumetric Computed Tomography Dose Index (CTDI Vol) for Head CT Examinations. — 64; 28.7 mGy
Graves' Disease
Primary: Dosimetry Studies
Cardiovascular Disease
Primary: Image Quality — 0.96 Proportion of images rated equal/better
Computed Tomography · Radiation Dosage
Primary: Skin Entrance Radiation Dose During Computed Tomography (CT) — 1775; 1325; 625; 259 mrad
Vascular Diseases
Primary: Image Quality — 0.85 proportion of readers
Radiation Exposure
Primary: Operator Exposure (OE)/Dose Area Product (DAP) (uSv[Micro-Sieverts]/mGy[Milligray]*cm2) of the Proximal Operator — 6.41; 3.51 10,000 x uSv / mGy*cm^2
Lymphoma, Follicular
Primary: Area Under the Curve (AUC) at 0 to 120, 0 to 168, and 0 to Infinity Hours — 1.04; 1.18; 1.39 %ID.h/mL
Diabetes
Primary: Dexcom G6 Accuracy Post Radiation Exposure by Clark Error Analysis (Zone A and B %) — 806; 1226; 704; 1715 Matched blood glucose readings — p=<0.05
Arrhythmias, Cardiac
Primary: Cumulative Dose Area Product (DAP) Value — 8.8; 15.3 Gy*cm^2 — p=<0.0001
Malignant Bone Tumors
Primary: Change in Bone Mineral Density (Tb. BMD) — 4.5; -39.3; -8.7; -54.7 mg/cm^3
Fanconi Anemia
Primary: Number of Participant With Neutrophil Recovery — 78 Participants
Low Grade Gliomas
Primary: Number of Participants With Late Effects > 3 Months Post RT — 20 Participants
Lung Cancer · Radiation Pneumonitis
Primary: Number of Participants With Radiation Pneumonitis — 8; 10 participants — p=0.05
Covid19 · Pneumonia, Viral
Primary: Count of White Blood Cells (WBC) After 99mTc-pertechnetate Aerosol Inhalation for Adverse Events Monitoring as Evaluation Safety of This Procedure in Patients With…
Radiation Toxicity
Primary: Tissue Oxygenation — 62.5 mmHg — p=0.5
Brain Tumor · Medulloblastoma · Pineoblastoma
Primary: Cumulative Incidence of Ototoxicity — 26; 27 percentage of participants
Breast Cancer
Primary: Number of Proteins Expressed Differently in Response to Receiving Radiation Therapy — 31 Proteins
Prostate Cancer
Primary: Treatment Tolerance (Genitourinary [GU] or Gastrointestinal [GI] Adverse Events) — 3 events
Benign Meningioma
Primary: Progression Free Survival — 91; 91; 86; 81 percentage of participants surviving — p=0.234
Cervical Cancer · Endometrial Cancer · Esophageal Cancer
Primary: Number of Participants Who Had Adequate High-Quality Brachytherapy Implants Reported Per Strata (Four Body Sites) and Combined Overall — 27; 0; 0; 14 Participants
Breast Cancer
Primary: Incidence of Implant Failure — 8; 17; 34; 41 Number of Participants with Implant Fail
Supraventricular Tachycardia
Primary: Total Fluoroscopy Time — 18.3; 7.5 minutes